Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

pantoprazole

pantoprazole
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Protonix DELAYED RELEASE TABLET, ORAL 20 mg    
Protonix DELAYED RELEASE TABLET, ORAL 40 mg      
Protonix DR GRANULE, ENTERIC COATED, ORAL 40 mg    
Protonix IV POWDER FOR INJECTION, INTRAVENOUS 40 mg      

VIEW MORE Proton-pump Inhibitors
CLASS
562836

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

pantoprazole (Protonix)

  • 20 mg delayed release tablet oral

pantoprazole (Protonix)

  • 40 mg delayed release tablet oral

Protonix DR tablet and DR oral suspension medication guide


The schedule for pantoprazole should be the same as that prescribed for the non-workhorse PPI.

Protonix DR granules for oral suspension are classified as non-formulary, not stocked. Interchange to Protonix tablets if possible. Pantoprazole tablets are delayed release and cannot be crushed. Use Prevacid SoluTab if for pediatric dosing or enteral tube administration.

Automatic IV to PO conversion per IV to oral conversion guidelines. IV to PO Conversion Guidelines


Per P&T approval, pharmacists are now able to discontinue inappropriately prescribed Proton Pump Inhibitors (all dosage forms of pantoprazole and omeprazole) as COSIGN REQUIRED in adult patients without proper indication for stress ulcer prophylaxis or other appropriate indication as indicated below.

**Exclusions: PPIs prescribed by GI physicians, home medications, and the criteria listed below.**

Criteria for use as stress ulcer prophylaxis:
   •Mechanical ventilation > 48 hours
   •Coagulopathy (in absence of an anticoagulant)
        •  Platelet count < 50, INR > 1.5, or PTT 2x baseline        
   •Use of 2 antiplatelet agents (Clopidogrel, aspirin, ticagrelor, etc.) 
   •Ulcer or GI bleed in the past year
   •Major trauma
   •Traumatic head injury or spinal cord injury
   •Partial hepatectomy/ hepatic failure 
   •Patients with TWO or more of the following risk factors:
        •Sepsis
        •ICU length of stay > 7 days
        •Occult bleeding > 6 days
        •High dose steroids
             Dexamethasone: 10 mg/day
             Methylprednisolone: 50 mg/day
             Prednisone: 60 mg/day
             Hydrocortisone: 250 mg/day    

      
PPI indications for treatment or maintenance prophylaxis:
   •Gastroesophageal Reflux Disease (GERD)
   •Gastric or duodenal ulcer
   •GI bleed
   •Erosive esophagitis
   •Helicobacter pylori treatment
   •Chronic NSAID therapy
   •Zollinger-Ellison Syndrome
   •Other appropriate maintenance therapy


Reviewed: October 28, 2008 (Protonix DR granules)


Last updated: Nov. 19, 2019







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.